Janice Schakowsky actually said...

But competition is actually most central to innovation--and the opposite of what Big Pharma wants.

So we owe it to the American people, and I will be doing everything I can in my power to do so.

Product hopping or evergreening is the reformulation of a drug by a brand-name manufacturer to delay competition and protect protection for ...

Competition is crucial to lowering prescription drug prices and improving America's access to lifesaving medication.